Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo de estudio
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Epilepsy Behav ; 23(3): 205-12, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22381390

RESUMEN

In this study, we isolated the alkaloid erysothrine from the hydroalcoholic extract of flowers from E. mulungu and screened for its anticonvulsant and anxiolytic actions based on neuroethological and neurochemical experiments. Our results showed that the administration of erysothrine inhibited seizures evoked by bicuculline, PTZ, NMDA and most remarkably, kainic acid. Also, erysothrine induced an increase in the number of entries but not in the time spent in the open arms of the EPM. However, we did not notice any alterations in the light-dark choice or in the open-field tests. In preliminary neurochemistry tests, we also showed that erysothrine (0.001-10 µg/mL) did not alter the GABA or glutamate synaptossomal uptake and binding. Altogether, our results describe an alkaloid with anticonvulsant activity and mild anxiolytic activity that might be considered well tolerated as it does not alter the general behavior of the animals in the used doses.


Asunto(s)
Alcaloides/uso terapéutico , Ansiolíticos/uso terapéutico , Anticonvulsivantes/uso terapéutico , Ansiedad/tratamiento farmacológico , Erythrina/química , Flores/química , Fitoterapia , Convulsiones/tratamiento farmacológico , Alcaloides/aislamiento & purificación , Animales , Ansiolíticos/aislamiento & purificación , Anticonvulsivantes/aislamiento & purificación , Ansiedad/etiología , Convulsivantes/toxicidad , Diazepam/uso terapéutico , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Interacciones Farmacológicas , Conducta Exploratoria/efectos de los fármacos , Ácido Glutámico/metabolismo , Locomoción/efectos de los fármacos , Masculino , Ratas , Ratas Wistar , Convulsiones/inducido químicamente , Sinaptosomas/efectos de los fármacos , Tritio/metabolismo , Ácido gamma-Aminobutírico/metabolismo
2.
Curr Pharm Des ; 28(14): 1187-1197, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35524676

RESUMEN

BACKGROUND: Ischemic stroke produces a large health impact worldwide, with scarce therapeutic options. OBJECTIVE: This study aimed to reveal the role of NADPH oxidase and neuroinflammatory genes in the cerebral anti-ischemic effects of C-Phycocyanin (C-PC), the chief biliprotein of Spirulina platensis. METHODS: Rats with either focal cerebral ischemia/reperfusion (I/R) or acute brain hypoperfusion, received C-PC at different doses, or a vehicle, for up to 6 h post-stroke. Neurological, behavioral and histochemical parameters were assessed in I/R rats at 24 h. Cerebral gene expression and hippocampal neuron viability were evaluated in hypoperfused rats at acute (24 h) or chronic phases (30 days), respectively. A molecular docking analysis of NOX2 and C-PC-derived Phycocyanobilin (PCB) was also performed. RESULTS: C-PC, obtained with a purity of 4.342, significantly reduced the infarct volume and neurological deficit in a dose-dependent manner, and improved the exploratory activity of I/R rats. This biliprotein inhibited NOX2 expression, a crucial NADPH oxidase isoform in the brain, and the superoxide increase produced by the ischemic event. Moreover, C-PC-derived PCB showed a high binding affinity in silico with NOX2. C-PC downregulated the expression of pro-inflammatory genes (IFN-γ, IL-6, IL-17A, CD74, CCL12) and upregulated immune suppressive genes (Foxp3, IL-4, TGF-ß) in hypoperfused brain areas. This compound also decreased chronic neuronal death in the hippocampus of hypoperfused rats. CONCLUSION: These results suggest that the inhibition of cerebral NADPH oxidase and the improvement of neuroinflammation are key mechanisms mediating the neuroprotective actions of C-PC against brain ischemia.


Asunto(s)
Isquemia Encefálica , Fármacos Neuroprotectores , Daño por Reperfusión , Animales , Isquemia Encefálica/tratamiento farmacológico , Isquemia Encefálica/metabolismo , Modelos Animales de Enfermedad , Simulación del Acoplamiento Molecular , NADPH Oxidasas/metabolismo , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Ficocianina/farmacología , Ficocianina/uso terapéutico , Ratas , Daño por Reperfusión/tratamiento farmacológico
3.
Basic Clin Pharmacol Toxicol ; 97(5): 289-95, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16236140

RESUMEN

Several investigations demonstrate that neurotoxins isolated from venoms of spiders and wasps may exert specific and selective activity on structures of the mammalian CNS. In the present work we examine the neurological effects of the low molecular weight compounds of the denatured venom of the neotropical social wasp Polybia occidentalis in freely moving rats. Central administration of denatured venom decreased the duration of exploratory, elevation and grooming behaviours on the open field. Moreover, denatured venom inhibited convulsing action of bicuculline (ED50 57 microg/microl), picrotoxin (ED50 75 microg/microl) and kainic acid (ED50 44 microg/microl), although it was ineffective against pentylenetetrazole-induced seizures. Despite of its inhibitory activity, toxic effects on motor performance examined in the rotarod test were not found, not even in extremely high doses. Also, denatured venom moderately reduced the spontaneous locomotor activity at anticonvulsant doses. These findings may indicate that the denatured venom has anticonvulsant activity with scarce propensity to cause neurological side-effects. Further studies are necessary to isolate the active compound and establish its mechanism of action.


Asunto(s)
Anticonvulsivantes , Conducta Animal/efectos de los fármacos , Venenos de Avispas/farmacología , Avispas/metabolismo , Aminoácidos/análisis , Animales , Cromatografía Líquida de Alta Presión , Convulsivantes , Femenino , Masculino , Actividad Motora/efectos de los fármacos , Síndromes de Neurotoxicidad/psicología , Equilibrio Postural/efectos de los fármacos , Desnaturalización Proteica , Ratas , Ratas Wistar , Convulsiones/inducido químicamente , Convulsiones/prevención & control , Venenos de Avispas/química , Venenos de Avispas/toxicidad
4.
Toxicon ; 40(10): 1399-406, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12368110

RESUMEN

Venom from male and female specimens of the medically most important Brazilian Ctenidae spider Phoneutria nigriventer (Keyserling, 1891) has been compared. Males showed a slightly higher venom yield (386 microg) than equal sized females (296 microg), while adult females showed nearly a three times higher venom yield (1079 microg). High-pressure liquid-chromatography analyses revealed differences in the venom composition between males and females. A single peak in HPLC (peak 11) was only detected in venom from females carrying egg-sacs, and sodium dodecyl sulfate-gel electrophoresis showed a series of high molecular weight proteins only in the male venom pool. The median lethal dose (LD(50)) in mice for female venom was 0.63 microg kg(-1) (95% confidence interval [0.54; 0.71] and 0.61 [0.56; 0.73] microg kg(-1)) for females with egg-sacs, when compared to the male venom which showed a LD(50) of 1.57 [1.46; 1.88] microg kg(-1). The venom of both sexes was also tested in insects using a termite bioassay with doses of 2, 3, 4, and 5 microg per termite. No effect was detected for the lowest dose of female venom, whereas all the other venom doses from both sexes caused a decreased paralysis time and death of the termites. Comparing the venom of both sexes, it was observed that female venom provoked a faster reaction than male venom. The results indicate that males and females of P.nigriventer have differing venom composition which lead to different effects in biological assays.


Asunto(s)
Caracteres Sexuales , Venenos de Araña/química , Venenos de Araña/toxicidad , Arañas/fisiología , Animales , Bioensayo , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Electroforesis en Gel de Poliacrilamida , Femenino , Inyecciones Intravenosas , Isópteros/efectos de los fármacos , Dosificación Letal Mediana , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Parálisis/inducido químicamente , Venenos de Araña/administración & dosificación
5.
Mol Pharmacol ; 72(5): 1228-37, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17646426

RESUMEN

Previous studies have shown that a compound purified from the spider Parawixia bistriata venom stimulates the activity of glial glutamate transporters and can protect retinal tissue from ischemic damage. To understand the mechanism by which this compound enhances transport, we examined its effects on the functional properties of glutamate transporters after solubilization and reconstitution in liposomes and in transfected COS-7 cells. Here, we demonstrate in both systems that Parawixin1 promotes a direct and selective enhancement of glutamate influx by the EAAT2 transporter subtype through a mechanism that does not alter the apparent affinities for the cosubstrates glutamate or sodium. In liposomes, we observed maximal enhancement by Parawixin1 when extracellular sodium and intracellular potassium concentrations are within physiological ranges. Moreover, the compound does not enhance the reverse transport of glutamate under ionic conditions that favor efflux, when extracellular potassium is elevated and the sodium gradient is reduced, nor does it alter the exchange of glutamate in the absence of internal potassium. These observations suggest that Parawixin1 facilitates the reorientation of the potassium-bound transporter, the rate-limiting step in the transport cycle, a conclusion further supported by experiments showing that Parawixin1 does not stimulate uptake by an EAAT2 transport mutant (E405D) defective in the potassium-dependent reorientation step. Thus, Parawixin1 enhances transport through a novel mechanism targeting a step in the transport cycle distinct from substrate influx or efflux and provides a basis for the design of new drugs that act allosterically on transporters to increase glutamate clearance.


Asunto(s)
Transportador 2 de Aminoácidos Excitadores/efectos de los fármacos , Glutamatos/metabolismo , Fármacos Neuroprotectores/farmacología , Venenos de Araña/farmacología , Animales , Transporte Biológico/efectos de los fármacos , Células COS , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Transportador 2 de Aminoácidos Excitadores/genética , Fármacos Neuroprotectores/análisis , Sodio/metabolismo , Venenos de Araña/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA